Navigation Links
Keystone Programs for Collaborative Discovery Launch at Fox Chase
Date:2/27/2008

PHILADELPHIA (Feb. 27, 2008) Fox Chase Cancer Center today announced the first four awards in an innovative new research program designed to bring the power of team-based science to bear on some of the most significant questions in cancer research. The Keystone Programs for Collaborative Discovery aim to accelerate the pace of medical progress against cancer.

At the heart of each of the four new Keystone Programs is a self-organized group of scientists, clinicians, and other research professionals seeking to integrate and focus their joined expertise on an important cancer problem. Selected after a competitive external peer-review process, each of the new Keystone Programs will receive at least $5 million in support over five years. The funding will come primarily from new sources, including Fox Chases Board of Directors and private philanthropy. Additional Keystone Programs are in development and will be added to the portfolio as soon as is feasible.

The Keystone Programs for Collaborative Discovery represent an unprecedented reimagining of Fox Chases research enterprise to seize the opportunities for progress against cancer unique to this moment in scientific history, says Michael V. Seiden, M.D., Ph.D., president and CEO of Fox Chase Cancer Center. In the post-genomic era, the next wave of major advances against disease will depend on self-assembled teams of researchers from different fields effectively pooling their skills and resources. The Keystone Programs were designed specifically to encourage and support the kind of creative team-based science at Fox Chase that will be required to solve the most challenging cancer problems.

The first four Keystone Programs for Collaborative Discovery are:

  • The Keystone Program in Personalized Risk and Prevention
    Goal: To discover molecular markers that predict cancer risk and to develop risk reduction strategies tailored to the profile and personal values of the individual

  • The Keystone Program in Epigenetics and Progenitor Cells
    Goal: To investigate two new views of the origins and maintenance of tumor cells with the aim of creating novel approaches to diagnosis, treatment, and prevention

  • The Keystone Program in Blood Cell Development and Cancer
    Goal: To identify the genes essential for blood precursor cells to give rise to the many distinct blood cell types, a critical step towards understanding blood cell cancers and improving the treatment of patients with leukemias and lymphomas

  • The Keystone Program in Personalized Kidney Cancer Therapy
    Goal: To investigate the mechanisms of kidney cancer metastasis and to uncover the molecular signals that anticipate how a kidney tumor will respond to therapies in order to optimize therapy for individual patients

In recent years, federal agencies funding biomedical research have recognized the importance of multidisciplinary team-based strategies for solving important disease problems. Funding mechanisms intended to support this kind of research include the Program Project Grants (P01) sponsored by a number of the National Institutes of Health and the Specialized Programs of Research Excellence (SPORE) supported by the National Cancer Institute, one of the NIH institutes.

In launching the Keystone Programs, Fox Chase Cancer Center is making a remarkable institutional commitment to promoting team-based research to accelerate discovery in cancer medicine, says Seiden. The scope of our investment in this program is unusual and may well be unique among academic research centers.

In confronting cancer, Fox Chase Cancer Center has two advantages over most other leading medical centers, according to Seiden, both of which will contribute to the success of the Keystone Programs. The first is its tight focus on only one major health problem. Unlike most medical centers, Fox Chase is dedicated solely to confronting the challenge of human cancer. A second pronounced advantage is Fox Chases intimate organizational culture, which encourages the kind of collaborative interactions among scientists and physicians that will drive the success of the Keystone Programs.

Twelve proposals for Keystone Programs funding were submitted for consideration by teams of Fox Chase researchers. At the invitation of Fox Chase president and CEO Seiden, an external scientific advisory panel of sixteen leading cancer scientists and clinicians agreed to review the proposals in detail to assess their scientific strengths. The panel also traveled to Fox Chase to listen to presentations by the proposal teams. The counsel provided by this independent group of advisors served to ensure the fairness of the award process, as well as the high quality of the winning programs.


'/>"/>

Contact: Franklin Hoke
franklin.hoke@fccc.edu
215-728-2700
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. Keystone Human Services Acquires Impact Systems, Inc.
2. Temple University Hospital, Temple University School of Medicine and Crozer-Keystone Health System Collaborate to Provide Comprehensive Kidney Care
3. MB Software Corporation Reaches Agreement with Keystone Equity Partners
4. AthletixNation.com Launches Sports Website and Community Programs
5. New Legal Momentum Publication Exposes How Abstinence-Only Programs Harm Women and Girls
6. New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
7. Portable Computer Devices Can Aid Exercise Programs
8. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
9. Bush Budget Cuts Federal Health Programs Vital to the Health of All Children
10. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
11. Training Magazine Applauds Aflacs Employee Learning Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: